Status:
COMPLETED
Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures.
Lead Sponsor:
Aarhus University Hospital
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective study on safety and Diagnostic yield in using cryobiopsies as a Diagnostic tool in diagnosing patients under investigation for Interstitial lung diseases. This includes a registration ...
Eligibility Criteria
Inclusion
- \>18years of age
- suspected of Interstitial lung Disease
- cryobiopsies performed.
Exclusion
- FVC below 50% of predicted
- DLCO below 35%
- Body Mass Index (BMI) above 35
- pulmonary hypertension with a tricuspidal gradient above 40 mmHg
- other cardiac or other comorbidities that would increase the risk of complications
Key Trial Info
Start Date :
November 6 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05311345
Start Date
November 6 2015
End Date
April 1 2020
Last Update
April 5 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.